Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Research Fellowships - Translational Focus 2020

Molecular classification of pancreatic cancer by gene expression analysis of circulating tumor DNA

Fellow: Elisabeth Bergen
Home institute: Vienna General Hospital (AKH) - Medizinische Universität Wien, Vienna, Austria
Host institute: Department of Gastroenterology and Gastrointestinal Oncology Department Georges Pompidou European Hospital,  Sorbonne Paris-Cité,  Université Paris-Descartes, Paris, France
Sponsor: ESMO

ENSURE study - Dendritic cell therapy combined with surgery in mesothelioma

Fellow: Luca Cantini
Home institute: Università Politecnica delle Marche - AOU Ospedali Riuniti Ancona, Ancona, Italy
Host institute: Erasmus MC Cancer Centre, Rotterdam, Netherlands
Sponsor: ESMO

The role of tumor-specific CD8+ T cells in tumor evolution and response to immune checkpoint inhibitors in cervical cancer patients.

Fellow: Giulia Costanza Leonardi
Home institute: Università degli Studi di Catania, Catania, Italy
Host institute: Cancer Research Center of Toulouse (CRCT, Inserm UMR 1037) and Institut Universitaire du Cancer de Toulouse – Oncopole (IUCT-O), Toulouse, France 
Sponsor: ESMO

Investigating the molecular mechanisms that regulate human breast cancer stem cell function in response to systemic therapy

Fellow: Long Nguyen
Home institute: Princess Margaret Cancer Centre, Toronto, Canada
Host institute: Cancer Research UK Cambridge Institute, Cambridge, United Kingdom
Sponsor: ESMO

Impact of microbiota on breast cancer prognosis and treatment efficacy

Fellow: Andri Papakonstantinou
Home institute: Karolinska Institutet, Solna, Sweden
Host institute: Vall d’Hebron Institute of Oncology, Barcelona, Spain
Sponsor: ESMO

Prognostic and therapeutic significance of treatment-induced intrinsic subtypes and genomic changes in Luminal breast tumors

Fellow: Francesco Schettini
Home institute: Azienda Ospedaliera Universitaria Federico II, Naples, Italy
Host institute: August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
Sponsor: ESMO

Characterisation of appendiceal adenocarcinoma by transcriptomic analysis and correlation with clinical outcomes: a step towards rational therapeutics

Fellow: Madeleine Strach
Home institute: Chris O'Brien Lifehouse, Lilyfield, Australia
Host institute: The Christie Colorectal and Peritoneal Oncology Research Group, Manchester Cancer Centre, Manchester, United Kingdom
Sponsor: ESMO

ESMO Research Fellowships - Clinical Focus 2020

Concurrent chemotherapy and PROton therapy coMpared to photon therapy, followed by Durvalumab maintEnance in sTagE III NOn-Small Cell Lung Cancer (NSCLC) (PROMETEO study): immunological and hematological effects.

Fellow: Francesco Cortiula
Home institute: CRO Aviano National Cancer Institute, Udine, Italy
Host institute: Maastricht University Medical Center+, Maastricht, Netherlands
Sponsor: ESMO

A prospective observational study to identify a composite biomarker for prediction and early detection of immunotherapy-related adverse events (irAEs)

Fellow: Aljosja Rogiers
Home institute: Melanoma Institute Australia, Sydney, Australia​
Host institute: The Royal Marsden NHS Foundation Trust, London, United Kingdom
Sponsor: ESMO

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings